0001371796-19-000001.txt : 20190211 0001371796-19-000001.hdr.sgml : 20190211 20190211140152 ACCESSION NUMBER: 0001371796-19-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190211 DATE AS OF CHANGE: 20190211 EFFECTIVENESS DATE: 20190211 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Solace Therapeutics Inc CENTRAL INDEX KEY: 0001371796 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-332570 FILM NUMBER: 19584468 BUSINESS ADDRESS: STREET 1: 135 NEWBURY STREET CITY: FRAMINGHAM STATE: MA ZIP: 01701 BUSINESS PHONE: 508-283-1200 MAIL ADDRESS: STREET 1: 135 NEWBURY STREET CITY: FRAMINGHAM STATE: MA ZIP: 01701 D 1 primary_doc.xml X0708 D LIVE 0001371796 Solace Therapeutics Inc 135 NEWBURY STREET FRAMINGHAM MA MASSACHUSETTS 01701 508-283-1200 DELAWARE None None Corporation true William H. Gruber 135 Newbury Street Framingham MA MASSACHUSETTS 01701 Executive Officer Director Kevin G. Connors 135 Newbury Street Framingham MA MASSACHUSETTS 01701 Executive Officer Director Ryan Drant 135 Newbury Street Framingham MA MASSACHUSETTS 01701 Director Ali Behbahani 135 Newbury Street Framingham MA MASSACHUSETTS 01701 Director John McDonough 135 Newbury Street Framingham MA MASSACHUSETTS 01701 Director Stacy Enxing Seng 135 Newbury Street Framingham MA MASSACHUSETTS 01701 Director Other Health Care Decline to Disclose 06b false 2019-01-31 false true false 0 2114965 1900000 214965 false 6 0 0 0 false Solace Therapeutics Inc William H. Gruber William H. Gruber President and Chief Executive Officer 2019-02-11